CANORGAN

CANORGAN
Product Description

This is a human-validation oncology and immuno-oncology platform that precisely recapitulates the actual tumor microenvironment (TME) utilizing patient-derived tumor tissues, patient-derived organoids (PDOs), immune cells, and the extracellular matrix (ECM). Through a multi-channel system, various immune cells are sequentially introduced into 3D spheroids to step-by-step recreate the tumor-immune response.

Read more Show less

ORGANOPlus Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Other
View company profile
Categories
more categories Show less
Specifications
  • Details
    - Evaluating the efficacy of anticancer and immuno-oncology therapeutics- Validating the selectivity and efficacy of ADCs and T-cell engagers (TCEs)- Assessing tissue responsiveness of RNA therapeutics such as siRNA -  Analyzing post-treatment Mechanism of Action (MoA) and biomarkers to advance patient-tailored precision medicine
  • Model
    solid tumor
More specifications Fewer specifications

ORGANOPlus Co., Ltd.

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Other
View company profile

More Products from ORGANOPlus Co., Ltd. (1)

  • VILLIORGAN

    Product VILLIORGAN

    This is a Gut-on-a-chip validation platform that biomimetically recapitulates the human intestinal villi, mucin layer, barrier function, and gut microbiota environment. Utilizing a 3D villi-shaped membrane structure, it establishes a co-culture environment with anaerobic microbes.